APO-QUETIAPINE
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is APO-QUETIAPINE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that APO-QUETIAPINE 25MG has been permanently discontinued (last updated June 25, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is APO-QUETIAPINE not available?
The reason the manufacturer reported: Business reasons.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
SEROQUEL
CHEPLAPHARM ARZNEIMITTEL GMBH
ACCEL-QUETIAPINE
ACCEL PHARMA INC
QUETIAPINE XR
Extended-ReleasePRO DOC LIMITEE
DOM-QUETIAPINE
DOMINION PHARMACAL
IPG-QUETIAPINE
MARCAN PHARMACEUTICALS INC
QUETIAPINE
SIVEM PHARMACEUTICALS ULC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02313901
Strength
25MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other (Please describe in comments)
Business reasons
Business reasons
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178